Company: OTSA
Filing Date: 2025-05-23
Form Type: DRS/A
Source: 0001213900-25-047247
Chunk: 99

Company: OTSAW Ltd
Filing Date: 2025-05-23
Form: DRS/A
Chunk 99
---
 information, future events or otherwise, except as may be required under applicable securities laws. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. 53

USE OF PROCEEDS Assuming we receive gross proceeds of US$[•] in this offering and assuming that the Underwriters do not exercise its over -allotmentoption, after deducting the underwriting discount and estimated offering expenses payable by us, we expect to receive net proceeds of approximately US$[•] from this offering. We intend to use the net proceeds of this offering as follows.

| Description of Use                                                                      |     | Estimated    
 Amount of    
 Net Proceeds |     |     | % Allocation of 
    Net Proceeds |
| Acquisition, Strategic Alliance, and Joint Ventures                                     |     | US$          | [•] |     |            [20] |
| Expansion of Production Capacity and Inventory in relation to TransCar 5.0 and Camello+ |     | US$          | [•] |     |            [40] |
| Market Expansion in the United States, United Kingdom, Europe, Asia and Australia       |     | US$          | [•] |     |            [10] |
| Research and Development in relation to TransCar 5.0 and Camello+                       |     | US$          | [•] |     |            [10] |
| Working capital                                                                         |     | US$          | [•] |     |            [20] |
| Total                                                                                   |     | US$          | [•] |     |             100 |

If the Underwriters exercise its over -allotmentoption in full, after deducting the underwriting discount and estimated offering expenses payable by us, we expect to receive an additional net proceeds of approximately $[ ]. We will use the additional proceeds for working capital purposes. The foregoing represents our current intentions based upon our present plans and business conditions to use and allocate the net proceeds of this offering. Our management, however, will have some flexibility and discretion to apply the